Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BBIO
HALO
Add up to 3 more stocks
BBIO
BridgeBio Pharma, Inc.
-0.32%
$65.93-0.21Delayed quote: Oct 6, 2026, 10:25 AM EDT
Market Cap
$12.91B
52W Range
$52.75 - $93.42
HALO
Halozyme Therapeutics, Inc.
-0.46%
$107.82-0.49Delayed quote: Oct 6, 2026, 10:25 AM EDT
Market Cap
$12.79B
52W Range
$61.23 - $116.85
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 32.18 |
| Forward P/E | N/A | 12.81 |
| PEG Ratio | N/A | 1.40 |
| P/B Ratio | N/A | 89.09 |
| P/S Ratio | 18.11 | 7.69 |
| P/FCF Ratio | N/A | 15.86 |
| EV/EBITDA | N/A | 14.00 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 93.3% | 78.2% |
| Operating Margin | -113.3% | 56.8% |
| Net Margin | -97.6% | 24.9% |
| ROE | N/A | 288.1% |
| ROA | -57.2% | 16.1% |
| ROIC | -62.1% | 27.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.23 | 2.71 |
| Quick Ratio | 1.17 | 2.31 |
| Debt/Equity | N/A | 14.95 |
| Interest Coverage | -10.72 | 45.03 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.